NCT04567615 2026-01-08A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase InhibitorsBristol-Myers SquibbPhase 2 Completed266 enrolled 28 charts